← Back to Search

Feedback on DBS Concentrations for Medication Adherence (ADD-ART Trial)

N/A
Waitlist Available
Led By Robert H Remien, Ph.D
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights

ADD-ART Trial Summary

This trial will give patients and their providers monthly feedback about their level of the drug Tenofovir-Diphosphate (TFV-DP) in order to study how this information affects patient and provider behavior.

ADD-ART Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Electronic Adherence (EA) Percentages
TFV-diphosphate (TFV-DP) Drug Level
Viral Load (VL) Assay

ADD-ART Trial Design

1Treatment groups
Experimental Treatment
Group I: Receiving Feedback From DBSExperimental Treatment1 Intervention
This arm of participants will receive monthly feedback from medical providers on their adherence measured through DBS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Feedback on DBS Concentrations
2020
N/A
~60

Find a Location

Who is running the clinical trial?

New York State Psychiatric InstituteLead Sponsor
475 Previous Clinical Trials
153,847 Total Patients Enrolled
Desmond Tutu HIV FoundationOTHER
14 Previous Clinical Trials
31,400 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,269 Previous Clinical Trials
5,481,409 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa
Robert Remien 2020. "Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04333498.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top